Postcoital contraception.
Thomas
M A
MA
University of Cincinnati Medical Center, Cincinnati, Ohio, USA.
D001291:Attitude of Health Personnel; D001294:Attitude to Health; D003281:Contraceptives, Postcoital / Q000737:chemistry / Q000494:pharmacology / Q000600:supply & distribution; D003613:Danazol / Q000494:pharmacology; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006282:Health Personnel / Q000193:education / Q000523:psychology; D006297:Health Services Accessibility / Q000458:organization & administration; D006801:Humans; D007435:Intrauterine Devices, Copper; D015735:Mifepristone / Q000494:pharmacology; D020380:Needs Assessment; D010353:Patient Education as Topic; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration
D003281:Contraceptives, Postcoital; D015735:Mifepristone; D003613:Danazol